News Curated ÃÛÌÒ´«Ã½ Channel: National Institute of Allergy and Infectious Diseases (NIAID) /articles/channels/National Institute of Allergy and Infectious Diseases (NIAID) This feature channel highlights experts, research, and feature stories related to National Institute of Allergy and Infectious Diseases (NIAID) en-us Copyright 2025 News News Curated ÃÛÌÒ´«Ã½ Channel: National Institute of Allergy and Infectious Diseases (NIAID) 115 31 / /images/newswise-logo-rss.gif Increased Cancer Risk for Kidney Transplant Recipients Linked to Epstein-Barr Virus /articles/increased-cancer-risk-for-kidney-transplant-recipients-linked-to-epstein-barr-virus/?sc=c6514 /articles/increased-cancer-risk-for-kidney-transplant-recipients-linked-to-epstein-barr-virus/?sc=c6514 Mon, 10 Feb 2025 10:00:04 EST All Journal ÃÛÌÒ´«Ã½,Cancer,Healthcare,Kidney Disease,Patient Safety,Transplantation,Grant Funded ÃÛÌÒ´«Ã½,National Institute of Allergy and Infectious Diseases (NIAID),National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Medical News Research Results More than 90% of the adult population in the U.S. is or has been infected with Epstein Barr virus (EBV). EBV is a highly contagious member of the herpes virus family, best known for causing infectious mononucleosis ("mono") and for its association with several cancers and autoimmune diseases. Kidney transplant patients who've never been exposed to EBV but receive organs from a donor who carried the virus may develop a life-threatening post-transplant complication called lymphoproliferative disorder (PTLD), according to a new study from the Perelman School of Medicine at the University of Pennsylvania. An estimated 4 to 5 percent of adult kidney transplants - as many as 1200 patients per year - could be at risk of the condition, in which the body's immune system gets confused and immune cells can grow out of control and act like cancer. The findings were recently published in Annals of Internal Medicine. Perelman School of Medicine at the University of Pennsylvania Nasal COVID-19 Vaccine Based on WashU Technology to Enter U.S. Clinical Trials /articles/nasal-covid-19-vaccine-based-on-washu-technology-to-enter-u-s-clinical-trials/?sc=c6514 /articles/nasal-covid-19-vaccine-based-on-washu-technology-to-enter-u-s-clinical-trials/?sc=c6514 Wed, 05 Feb 2025 19:00:22 EST Biotech,Clinical Trials,Immunology,Infectious Diseases,Vaccines,Coronavirus,National Institute of Allergy and Infectious Diseases (NIAID),National Institutes of Health (NIH) Business News Announcement A nasal vaccine for COVID-19 - based on technology developed at Washington University in St. Louis - is poised to enter a phase 1 clinical trial in the U.S. Washington University in St. Louis As the Protein Data Bank Thrives, Its Funding is Renewed at Increased Levels /articles/as-the-protein-data-bank-thrives-its-funding-is-renewed-at-increased-levels/?sc=c6514 /articles/as-the-protein-data-bank-thrives-its-funding-is-renewed-at-increased-levels/?sc=c6514 Tue, 14 Jan 2025 20:10:40 EST Budgets and Funding,Healthcare,Infectious Diseases,National Cancer Institute (NCI),National Institute of Allergy and Infectious Diseases (NIAID),National Institute of General Medical Sciences (NIGMS) Medical ÃÛÌÒ´«Ã½,Science News Feature <img src="/legacy/image.php?image=/images/uploads/2025/01/14/6786c6698eb10_197-ZikaVirus-5ireglycPROMO.jpg&width=100&height=150" alt="ÃÛÌÒ´«Ã½ image" />Federal science agencies have renewed and increased funding for a world-renowned digital archive of protein structures housed by Rutgers University-New Brunswick, an open-access data resource that has enabled research in everything from agriculture to zoology and has laid the groundwork for Nobel Prize-winning discoveries. /articles//images/uploads/2025/01/14/6786c6698eb10_197-ZikaVirus-5ireglycPROMO.jpg Rutgers University-New Brunswick NIH Announces Awards to Advance Tech for HIV Viral Load Detection /articles/nih-announces-awards-to-advance-tech-for-hiv-viral-load-detection/?sc=c6514 /articles/nih-announces-awards-to-advance-tech-for-hiv-viral-load-detection/?sc=c6514 Thu, 19 Dec 2024 19:55:08 EST AIDS and HIV,Biotech,Budgets and Funding,Infectious Diseases,Sex and Relationships,Technology,Grant Funded ÃÛÌÒ´«Ã½,National Institute of Allergy and Infectious Diseases (NIAID),National Institute of Biomedical Imaging and Bioengineering (NIBIB),National Institutes of Health (NIH) Medical ÃÛÌÒ´«Ã½,Business News Announcement NIH awarded more than $4 million in funds and support services to three diagnostic technology developers as part of the RADx Tech's Advanced Platforms for HIV Viral Load Monitoring program. National Institute of Biomedical Imaging and Bioengineering New Research Could Pave Way for Vaccine Against Deadly Wildlife Disease /articles/new-research-could-pave-way-for-vaccine-against-deadly-wildlife-disease/?sc=c6514 /articles/new-research-could-pave-way-for-vaccine-against-deadly-wildlife-disease/?sc=c6514 Tue, 19 Nov 2024 15:35:18 EST Biotech,Immunology,Vaccines,Wildlife,Budgets and Funding,National Institute of Allergy and Infectious Diseases (NIAID) Medical News Announcement <img src="/legacy/image.php?image=/images/uploads/2024/11/19/673cf7c6014d9_Image1.jpg&width=100&height=150" alt="ÃÛÌÒ´«Ã½ image" />Sean Crosson, a Professor Rudolph Hugh Endowed Chair in Michigan State University's Department of Microbiology, Genetics and Immunology, has been awarded a $2.4 million grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases to study the cause of that very disease, Brucella abortus. /articles//images/uploads/2024/11/19/673cf7c6014d9_Image1.jpg,/images/uploads/2024/11/19/673cf7dd11d95_Image2.jpg Michigan State University Study: AI Could Transform How Hospitals Produce Quality Reports /articles/study-ai-could-transform-how-hospitals-produce-quality-reports/?sc=c6514 /articles/study-ai-could-transform-how-hospitals-produce-quality-reports/?sc=c6514 Mon, 21 Oct 2024 11:35:46 EST NEJM,All Journal ÃÛÌÒ´«Ã½,Artificial Intelligence,Technology,National Institute of Allergy and Infectious Diseases (NIAID),National Institute of General Medical Sciences (NIGMS),Top Clipped Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2024/10/21/67167510313bd_AI-study-Teale-Longhurst-GettyImages-1327568875.jpg&width=100&height=150" alt="ÃÛÌÒ´«Ã½ image" />University of California San Diego School of Medicine researchers find advanced AI could lead to easier, faster and more efficient hospital quality reporting. /articles//images/uploads/2024/10/21/67167510313bd_AI-study-Teale-Longhurst-GettyImages-1327568875.jpg UC San Diego Health Houston Methodist Prepares for Next Pandemic as Part of National NIH-Funded Consortium /articles/houston-methodist-prepares-for-next-pandemic-as-part-of-national-nih-funded-consortium/?sc=c6514 /articles/houston-methodist-prepares-for-next-pandemic-as-part-of-national-nih-funded-consortium/?sc=c6514 Thu, 03 Oct 2024 19:05:13 EST Biotech,Budgets and Funding,Healthcare,Immunology,Infectious Diseases,Grant Funded ÃÛÌÒ´«Ã½,National Institute of Allergy and Infectious Diseases (NIAID),National Institutes of Health (NIH) Medical News Feature The question isn't if, but when, the next pandemic will hit. Research and observation have identified strong potential for the next pandemic-causing virus to come from one or more of five different virus families. Houston Methodist Triple Antibody Therapy Shows Promise for Long-Lasting HIV Control /articles/triple-antibody-therapy-shows-promise-for-long-lasting-hiv-control/?sc=c6514 /articles/triple-antibody-therapy-shows-promise-for-long-lasting-hiv-control/?sc=c6514 Thu, 12 Sep 2024 09:05:26 EST AIDS and HIV,All Journal ÃÛÌÒ´«Ã½,Infectious Diseases,Grant Funded ÃÛÌÒ´«Ã½,National Institute of Allergy and Infectious Diseases (NIAID),National Institutes of Health (NIH),Nature (journal) Medical News Research Results In a study of 12 participants, researchers at Beth Israel Deaconess Medical Center (BIDMC) have demonstrated that a cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV. A subset of participants also demonstrated long-term control of the virus months after antibody levels declined to low or undetectable. Beth Israel Lahey Health T helper cells may be the key to improving annual influenza vaccines /articles/t-helper-cells-may-be-the-key-to-improving-annual-influenza-vaccines/?sc=c6514 /articles/t-helper-cells-may-be-the-key-to-improving-annual-influenza-vaccines/?sc=c6514 Tue, 20 Aug 2024 10:05:28 EST All Journal ÃÛÌÒ´«Ã½,Immunology,Infectious Diseases,Public Health,Vaccines,Grant Funded ÃÛÌÒ´«Ã½,National Institute of Allergy and Infectious Diseases (NIAID),National Institutes of Health (NIH),Nature (journal) Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2024/08/20/66c4ae313ad5a_00214410-010AG.jpg&width=100&height=150" alt="ÃÛÌÒ´«Ã½ image" />The annual influenza vaccination provides updated protection against the virus but could be improved as there is large variability in its efficacy. /articles//images/uploads/2024/08/20/66c4ae313ad5a_00214410-010AG.jpg St. Jude Children's Research Hospital Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients /articles/long-term-study-reaffirms-benefits-of-covid-19-vaccination-for-organ-transplant-recipients/?sc=c6514 /articles/long-term-study-reaffirms-benefits-of-covid-19-vaccination-for-organ-transplant-recipients/?sc=c6514 Fri, 18 Aug 2023 12:05:42 EST All Journal ÃÛÌÒ´«Ã½,Autoimmune Diseases,Immunology,Infectious Diseases,Transplantation,Vaccines,Coronavirus,JAMA,National Institute of Allergy and Infectious Diseases (NIAID),National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),National Institutes of Health (NIH),Grant Funded ÃÛÌÒ´«Ã½,Top Hit Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2023/08/17/64de7f8765462_MichaelAug18SARSCoV2PhotoandModelBothNIAIDImage.jpg&width=100&height=150" alt="ÃÛÌÒ´«Ã½ image" />A two-year study found that spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus' omicron subvariant. /articles//images/uploads/2023/08/17/64de7f8765462_MichaelAug18SARSCoV2PhotoandModelBothNIAIDImage.jpg Johns Hopkins Medicine Immune cells present long before infection predict flu symptoms /articles/immune-cells-present-long-before-infection-predict-flu-symptoms/?sc=c6514 /articles/immune-cells-present-long-before-infection-predict-flu-symptoms/?sc=c6514 Thu, 17 Aug 2023 12:35:01 EST All Journal ÃÛÌÒ´«Ã½,Cell Biology,Immunology,Infectious Diseases,Public Health,Influenza,National Institute of Allergy and Infectious Diseases (NIAID),Nature (journal),Grant Funded News Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2023/08/17/64de48e9b8359_WebbyandThomas.jpg&width=100&height=150" alt="ÃÛÌÒ´«Ã½ image" />St. Jude Children's Research Hospital scientists found that immune cells present in individuals long before influenza infection predict whether the illness is symptomatic. /articles//images/uploads/2023/08/17/64de48e9b8359_WebbyandThomas.jpg St. Jude Children's Research Hospital UTSW finds potential key to predict immunotherapy toxicity /articles/utsw-finds-potential-key-to-predict-immunotherapy-toxicity/?sc=c6514 /articles/utsw-finds-potential-key-to-predict-immunotherapy-toxicity/?sc=c6514 Mon, 14 Aug 2023 11:50:25 EST All Journal ÃÛÌÒ´«Ã½,Autoimmune Diseases,Cancer,Cell Biology,Immunology,National Institute of Allergy and Infectious Diseases (NIAID) Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2023/08/14/64da4a9653de7_gerber-e-david.jpg&width=100&height=150" alt="ÃÛÌÒ´«Ã½ image" />Researchers at UT Southwestern Medical Center have identified a novel parameter of T cells that could help oncologists anticipate which patients would be most likely to develop immunotherapy toxicity. The findings, published in the Journal for ImmunoTherapy of Cancer, could lead to improved treatments for a variety of cancers. /articles//images/uploads/2023/08/14/64da4a9653de7_gerber-e-david.jpg UT Southwestern Medical Center Academic-private partnership aims to reduce toxic effects of deadly digestive bacteria /articles/academic-private-partnership-aims-to-reduce-toxic-effects-of-deadly-digestive-bacteria/?sc=c6514 /articles/academic-private-partnership-aims-to-reduce-toxic-effects-of-deadly-digestive-bacteria/?sc=c6514 Wed, 09 Aug 2023 10:20:28 EST Digestive Disorders,Grant Funded ÃÛÌÒ´«Ã½,National Institute of Allergy and Infectious Diseases (NIAID) Medical News Announcement The bacterium commonly referred to as C. diff is sometimes called "C-difficult" because it is so hard to treat, said Mohamed Seleem, director of the Center for One Health Research. Seleem and Nectagen Inc. have received a nearly $275,000 grant from the National Institute of Allergy and Infectious Diseases to study whether synthetic proteins developed by Nectagen can reduce the toxicity of the digestive bacteria. Virginia Tech Alternative cellular 'fuels' boost immunity /articles/alternative-cellular-fuels-boost-immunity/?sc=c6514 /articles/alternative-cellular-fuels-boost-immunity/?sc=c6514 Fri, 28 Jul 2023 11:05:11 EST All Journal ÃÛÌÒ´«Ã½,Cancer,Cell Biology,Immunology,Infectious Diseases,National Institute of Allergy and Infectious Diseases (NIAID),National Institutes of Health (NIH),Grant Funded ÃÛÌÒ´«Ã½,Top Hit Stories,Top Clipped Stories Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2023/07/28/64c3cb49090f2_Dr.RussellJonesCourtesyofVanAndelInstitute.jpg&width=100&height=150" alt="ÃÛÌÒ´«Ã½ image" />A metabolic by-product that is more prevalent during fasting may supercharge immune cells as they fight infection and disease, reports an early stage study by Van Andel Institute scientists and collaborators. /articles//images/uploads/2023/07/28/64c3cb49090f2_Dr.RussellJonesCourtesyofVanAndelInstitute.jpg Van Andel Institute Study explores how often children diagnosed with flu experience serious neuropsychiatric side effects /articles/study-explores-how-often-children-diagnosed-with-flu-experience-serious-neuropsychiatric-side-effects/?sc=c6514 /articles/study-explores-how-often-children-diagnosed-with-flu-experience-serious-neuropsychiatric-side-effects/?sc=c6514 Mon, 24 Jul 2023 11:40:35 EST All Journal ÃÛÌÒ´«Ã½,Children's Health,Infectious Diseases,Neuro,Patient Safety,Psychology and Psychiatry,Influenza,JAMA,National Institute of Allergy and Infectious Diseases (NIAID),National Institutes of Health (NIH) Medical News Research Results <img src="/legacy/image.php?image=/images/uploads/2023/07/24/64be983a9e078_JamesAntoon.jpeg&width=100&height=150" alt="ÃÛÌÒ´«Ã½ image" />While the incidence of influenza-associated neuropsychiatric events in children in the United States is unknown, the controversy over the use of a common antiviral medication typically administered to treat flu in children has sparked concern among parents and medical professionals alike. The dilemma about whether the treatment causes neuropsychiatric events or if the infection itself is the culprit, led a group of pediatric researchers at Monroe Carell Jr. /articles//images/uploads/2023/07/24/64be983a9e078_JamesAntoon.jpeg Vanderbilt University Medical Center ASBMB expresses concerns on proposed NIH budget cuts /articles/asbmb-expresses-concerns-on-proposed-nih-budget-cuts/?sc=c6514 /articles/asbmb-expresses-concerns-on-proposed-nih-budget-cuts/?sc=c6514 Fri, 21 Jul 2023 10:00:10 EST FASEB channel,Cell Biology,Chemistry,Ethics and Research Methods,Government and Law,National Institute of Allergy and Infectious Diseases (NIAID),National Institutes of Health (NIH),FASEB channel,FASEB channel,Top Hit Stories Medical ÃÛÌÒ´«Ã½,Science News Policy ASBMB publishes a statement expressing concerns for NIH budget cuts outlined by a House Labor HHS funding bill that could lead to lost jobs and halted research progress American Society for Biochemistry and Molecular Biology (ASBMB) New Community Partnership Model Boosts Inclusion of Participants into HIV Cure-Directed Research /articles/new-community-partnership-model-boosts-inclusion-of-participants-into-hiv-cure-directed-research/?sc=c6514 /articles/new-community-partnership-model-boosts-inclusion-of-participants-into-hiv-cure-directed-research/?sc=c6514 Wed, 19 Jul 2023 12:05:09 EST AIDS and HIV,All Journal ÃÛÌÒ´«Ã½,Clinical Trials,Ethics and Research Methods,Infectious Diseases,Public Health,National Institute of Allergy and Infectious Diseases (NIAID),National Institute of Mental Health (NIMH),National Institute of Neurological Disorders and Stroke (NINDS),National Institute on Drug Abuse (NIDA) Medical ÃÛÌÒ´«Ã½,Science News Research Results <img src="/legacy/image.php?image=/images/uploads/2023/07/19/64b8070474f85_Luisgrpshot.jpg&width=100&height=150" alt="ÃÛÌÒ´«Ã½ image" />Scientists have long used community advisory boards to engage communities and provide feedback on studies, but this model has limitations. Now, Wistar Institute researchers are sharing how a more inclusive model for community engagement can lead to deeper insights and greater community participation in HIV research. /articles//images/uploads/2023/07/19/64b8070474f85_Luisgrpshot.jpg Wistar Institute Virginia Tech awarded grant to study lingering Lyme disease symptoms /articles/virginia-tech-awarded-grant-to-study-lingering-lyme-disease-symptoms/?sc=c6514 /articles/virginia-tech-awarded-grant-to-study-lingering-lyme-disease-symptoms/?sc=c6514 Fri, 14 Jul 2023 16:05:18 EST Environmental Health,Public Health,Grant Funded ÃÛÌÒ´«Ã½,National Institute of Allergy and Infectious Diseases (NIAID),National Institutes of Health (NIH) Medical News Announcement An estimated 1,200 Americans, on average, are diagnosed with Lyme disease each day. Some of those patients continue to experience negative effects, even after treatment. Lyme disease researcher Brandon Jutras, associate professor in the College of Agriculture and Life Sciences and affiliated faculty of the Fralin Life Sciences Institute, recently received a $2. Virginia Tech Proteins Predict Significant Step Toward Development of Diabetes /articles/proteins-predict-significant-step-toward-development-of-diabetes/?sc=c6514 /articles/proteins-predict-significant-step-toward-development-of-diabetes/?sc=c6514 Thu, 29 Jun 2023 11:00:00 EST All Journal ÃÛÌÒ´«Ã½,Autoimmune Diseases,Children's Health,Diabetes,National Institute of Allergy and Infectious Diseases (NIAID),National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),National Institute of Environmental Health Sciences (NIEHS),National Institute of General Medical Sciences (NIGMS),Cell (journal),DOE Science ÃÛÌÒ´«Ã½ Source,Top Hit Stories,Top Clipped Stories Medical News Research Results Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear. Pacific Northwest National Laboratory Icahn School of Medicine at Mount Sinai Researchers Awarded $15.1 Million Grant to Explore Immune Rejection of Transplanted Organs /articles/icahn-school-of-medicine-at-mount-sinai-researchers-awarded-15-1-million-grant-to-explore-immune-rejection-of-transplanted-organs/?sc=c6514 /articles/icahn-school-of-medicine-at-mount-sinai-researchers-awarded-15-1-million-grant-to-explore-immune-rejection-of-transplanted-organs/?sc=c6514 Wed, 28 Jun 2023 15:05:19 EST Immunology,Transplantation,Grant Funded ÃÛÌÒ´«Ã½,National Institute of Allergy and Infectious Diseases (NIAID),All Journal News Medical News Announcement Striving to improve organ transplant survival rates, internationally renowned researchers in immunology and bioengineering at the Icahn School of Medicine at Mount Sinai have received $15.1 million from the National Institute of Allergy and Infectious Diseases (NIAID) to lead a novel, five-year multi-center research program that will explore trained immunity--the innate immune system's ability to remember infections and other insults--as a target for preventing organ transplant rejection. Mount Sinai Health System